Asahi Kasei Corp.: Asahi Kasei Medical to Acquire Bionova Scientific, U.S.-based Biopharmaceutical CDMO

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant

Related Keywords

Fremont ,California ,United States ,Austria ,Austrian ,Entwicklung Gmb ,Shizuka Nawa ,Asahi Kasei Corp ,Asahi Kasei Group ,Bionique Testing Laboratories ,Corporate Communications ,Bionova Scientific ,Corporate Profile Of Bionova Scientific ,Asahi Kasei Medical ,Scientific Main Facility ,Business Wire ,Asahi Kasei ,Virusure Forschung ,Entwicklung Gmbh ,Great Point Partners ,Asahi ,Kasei ,Orp ,Medical ,Cquire ,Bionova ,Cientific ,Ased ,Iopharmaceutical ,Dmo ,